PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.07%, EPS grew 45.5%, free cash flow grew 220.5% and total debt fell 4.30%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow PACS
PACS Group, Inc. (PACS) EV/Sales
As of 16 October 2026, PACS Group, Inc. (PACS) trades at a EV/Sales of 1.4×. Over the past ten years it has ranged from 0.2× (September 2025) to 1.9× (September 2024); the current reading is higher than 82% of that period. That is in line with the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.2× | 134.07% |
| FY2024 | 0.5× | (54.97%) |
| FY2023 | 1.1× | 0.00% |
| FY2022 | 1.1× | 0.00% |
| FY2021 | 1.1× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.2× | 31.17% |
| Mar 2026 | 0.9× | (19.38%) |
| Dec 2025 | 1.2× | 191.77% |
| Sep 2025 | 0.4× | (3.14%) |
| 10 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.8× |
| UHS Universal Health Services, Inc. compare | 0.9× |
| OPCH Option Care Health, Inc. compare | 1.0× |
| PACS PACS Group, Inc. | 1.4× |
| DVA DaVita Inc. compare | 1.6× |
| ENSG The Ensign Group, Inc. compare | 1.8× |
| CHE Chemed Corporation compare | 2.6× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.7× |
| LFST LifeStance Health Group, Inc. compare | 2.9× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)